“…The following supporting information can be downloaded at , Figure S1: Flowchart showing approach to data collection, curation process, and range of sequence lengths for the three Beta-CoVs used in the study by [ 39 ], Figure S2: Volcano plots showing the differential expression profiling of mock cultures of Calu-3 cells infected with Beta-CoVs between the final and initial time (MM), Figure S3: Potential common miRNA:virusRNA pairings predicted by RNAhybrid, miRanda, and mirTarP in Beta-CoVs , Figure S4: Comparison of vsRNAs encoded by Beta-CoVs across hosts of bats, intermediate animals, and humans, Figure S5: Number of predicted targets in the human genome for each vsRNA candidate in the three Beta-CoVs , Table S1: DEGs of Beta-CoVs using a |log 2 FC| > 1.5 and FDR < 0.05, Table S2: Full list of hsa-miRNAs targeting Beta-CoVs highly supported by either computational or experimental studies [ 35 , 66 , 67 , 68 , 69 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 ], Table S3: Number of hsa-miRNA:3′UTR interactions resulting from RNAhybrid, miRanda, and mirTarP overlaps, Table S4: Number of hsa-miRNA:viralRNA interactions resulting from RNAhybrid, miRanda, and mirTarP overlaps, Table S5: Repertoire of identified vsRNAs in Beta-CoV genomes using RNA–RNA interactions, Table S6: Number of targets identified for SARS-CoV by vsRNAs, Table S7: Number of targets identified for MERS-CoV by vsRNAs, Table S8: Number of targets identified for SARS-CoV-2 by vsRNAs, Table S9: Functional enrichment of DEGs that are possibly silenced by vsRNAs identified in ...…”